Trial Profile
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary)
- Indications Bacterial infections; Nosocomial infections
- Focus Pharmacokinetics
- 20 Nov 2013 Treatment table added.
- 13 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 08 Apr 2009 Planned end date changed from 1 Dec 2008 to 1 Apr 2009 as reported by ClinicalTrials.gov.